These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Current opinions about the etiology and pathogenesis of autosomal dominant polycystic kidney disease (ADPKD). I. Selected genetic aspects and mechanisms of cyst formation]. Jasik P; Sułowicz W; Kraśniak A; Stompór T Przegl Lek; 1998; 55(10):542-8. PubMed ID: 10224870 [TBL] [Abstract][Full Text] [Related]
25. Linkage analysis of families with autosomal dominant polycystic kidney disease by KG8-CA marker. Yuan CF; Lin CY; Chen TW; Yang ML; Ng HT Zhonghua Yi Xue Za Zhi (Taipei); 1997 Sep; 60(3):125-9. PubMed ID: 9419947 [TBL] [Abstract][Full Text] [Related]
26. Novel method for genomic analysis of PKD1 and PKD2 mutations in autosomal dominant polycystic kidney disease. Tan YC; Blumenfeld JD; Anghel R; Donahue S; Belenkaya R; Balina M; Parker T; Levine D; Leonard DG; Rennert H Hum Mutat; 2009 Feb; 30(2):264-73. PubMed ID: 18837007 [TBL] [Abstract][Full Text] [Related]
27. Molecular genetic analysis of polycystic kidney disease 1 and polycystic kidney disease 2 mutations in pedigrees with autosomal dominant polycystic kidney disease. Bitarafan F; Garshasbi M J Res Med Sci; 2019; 24():44. PubMed ID: 31160911 [TBL] [Abstract][Full Text] [Related]
28. Autosomal dominant polycystic kidney disease: comprehensive mutation analysis of PKD1 and PKD2 in 700 unrelated patients. Audrézet MP; Cornec-Le Gall E; Chen JM; Redon S; Quéré I; Creff J; Bénech C; Maestri S; Le Meur Y; Férec C Hum Mutat; 2012 Aug; 33(8):1239-50. PubMed ID: 22508176 [TBL] [Abstract][Full Text] [Related]
29. Mutation analysis in PKD1 of Japanese autosomal dominant polycystic kidney disease patients. Inoue S; Inoue K; Utsunomiya M; Nozaki J; Yamada Y; Iwasa T; Mori E; Yoshinaga T; Koizumi A Hum Mutat; 2002 Jun; 19(6):622-8. PubMed ID: 12007219 [TBL] [Abstract][Full Text] [Related]
30. Alport syndrome. Molecular genetic aspects. Hertz JM Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970 [TBL] [Abstract][Full Text] [Related]
31. Autosomal dominant polycystic kidney disease (ADPKD, MIM 173900, PKD1 and PKD2 genes, protein products known as polycystin-1 and polycystin-2). Boucher C; Sandford R Eur J Hum Genet; 2004 May; 12(5):347-54. PubMed ID: 14872199 [TBL] [Abstract][Full Text] [Related]
32. Usefulness of combined genetic data in Hungarian families affected by autosomal dominant polycystic kidney disease. Endreffy E; Maróti Z; Bereczki C; Túri S Mol Cell Probes; 2009 Feb; 23(1):39-43. PubMed ID: 19056484 [TBL] [Abstract][Full Text] [Related]
33. Association of mutation position in polycystic kidney disease 1 (PKD1) gene and development of a vascular phenotype. Rossetti S; Chauveau D; Kubly V; Slezak JM; Saggar-Malik AK; Pei Y; Ong AC; Stewart F; Watson ML; Bergstralh EJ; Winearls CG; Torres VE; Harris PC Lancet; 2003 Jun; 361(9376):2196-201. PubMed ID: 12842373 [TBL] [Abstract][Full Text] [Related]
34. A single-center analysis of genotype-phenotype characteristics of Chinese patients with autosomal dominant polycystic kidney disease by targeted exome sequencing. Yan Z; Wang Y; Deng W; Zhou Y; Hu Y; Qi K; Liu D; Xia R; Liu R; Zeng W; Zhang W; Xu J; Xiong F; Miao Y Front Genet; 2022; 13():934463. PubMed ID: 36186434 [No Abstract] [Full Text] [Related]
35. Cardiovascular characterization of Pkd2(+/LacZ) mice, an animal model for the autosomal dominant polycystic kidney disease type 2 (ADPKD2). Stypmann J; Engelen MA; Orwat S; Bilbilis K; Rothenburger M; Eckardt L; Haverkamp W; Horst J; Dworniczak B; Pennekamp P Int J Cardiol; 2007 Aug; 120(2):158-66. PubMed ID: 17182135 [TBL] [Abstract][Full Text] [Related]
36. Screening of the PKD1 duplicated region reveals multiple single nucleotide polymorphisms and a de novo mutation in Hellenic polycystic kidney disease families. Koptides M; Mean R; Demetriou K; Constantinides R; Pierides A; Harris PC; Deltas CC Hum Mutat; 2000 Aug; 16(2):176. PubMed ID: 10923040 [TBL] [Abstract][Full Text] [Related]
37. Characterization of microsatellite markers to diagnose ADPKD. Bae Y; Kim H; Paik M; Lee J; Hwang D; Hwang Y; Ahn C; Kang S Mol Cell Probes; 2004 Jun; 18(3):155-9. PubMed ID: 15135448 [TBL] [Abstract][Full Text] [Related]
38. Co-inheritance of a PKD1 mutation and homozygous PKD2 variant: a potential modifier in autosomal dominant polycystic kidney disease. Dedoussis GV; Luo Y; Starremans P; Rossetti S; Ramos AJ; Cantiello HF; Katsareli E; Ziroyannis P; Lamnissou K; Harris PC; Zhou J Eur J Clin Invest; 2008 Mar; 38(3):180-90. PubMed ID: 18257781 [TBL] [Abstract][Full Text] [Related]
39. Icelandic families with autosomal dominant polycystic kidney disease: families unlinked to chromosome 16p13.3 revealed by linkage analysis. Fossdal R; Böthvarsson M; Asmundsson P; Ragnarsson J; Peters D; Breuning MH; Jensson O Hum Genet; 1993 Jul; 91(6):609-13. PubMed ID: 8340115 [TBL] [Abstract][Full Text] [Related]
40. Prediction of Renal Prognosis in Patients with Autosomal Dominant Polycystic Kidney Disease Using PKD1/PKD2 Mutations. Kataoka H; Fukuoka H; Makabe S; Yoshida R; Teraoka A; Ushio Y; Akihisa T; Manabe S; Sato M; Mitobe M; Tsuchiya K; Nitta K; Mochizuki T J Clin Med; 2020 Jan; 9(1):. PubMed ID: 31948117 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]